Abstract
As life expectancy continues to increase and biotechnology advances, the use of cardiovascular implantable devices will continue to rise. Unfortunately, despite modern medical advances, the infection and mortality rates remain excessively elevated. This article reviews the pathophysiology and general concepts of cardiac device–related infections, including the physical and chemical characteristics of the medical device, host response to the medical device, and the microbiologic virulence factors. Infections of the most commonly utilized cardiovascular implantable devices, including cardiovascular implantable electronic devices, bioprosthetic and mechanical valves, ventricular assist devices, total artificial hearts, and coronary artery stents, are reviewed in detail.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990–1999. Am Heart J. 2004;47:582–6.
Monkowski DH, Axelrod P, Fekete T, et al. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation. Transpl Infect Dis. 2007;9:114–20.
Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422–9.
Darouiche RO. Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis. 2001;33:1567–72.
Phaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev. 1988;1:281–99.
•• Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458–77. The most up-to-date guideline of infections of cardiovascular implantable electronic devices..
Baddour LM, Bettmann MA, Bolger AF, et al. Nonvalvular cardiovascular device-related infections. Circulation. 2003;108:2015–31.
Kreutzer J, Ryan CA, Gauvreau K, et al. Healing response to the Clamshell device for closure of intracardiac defects in humans. Catheter Cardiovasc Interv. 2001;54:101–11.
Lin K, Hsu PP, Chen BP, et al. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci USA. 2000;97:9385–9.
Fisher AB, Chien S, Barakat AI, et al. Endothelial cellular response to altered shear stress. Am J Physiol Lung Cell Mol Physiol. 2001;281:L529–33.
Shive MS, Hasan SM, Anderson JM. Shear stress effects on bacterial adhesion, leukocyte adhesion, and leukocyte oxidative capacity on a polyetheurethane. J Biomed Mater Res. 1999;46:511–9.
Ankersmit HJ, Tugulea S, Spanier T, et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet. 1999;354:550–5.
Heilmann C, Schweitzer O, Gerke C, et al. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol Microbiol. 1996;20:1083–91.
Francois P, Vaudaux P, Lew PD. Role of plasma and extracellular matrix proteins in the pathophysiology of foreign body infections. Ann Vasc Surg. 1998;12:34–40.
Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect. 2002;4:481–9.
•• Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33:414–9. The authors clearly articulate the disproportional increase in the number of infections of cardiovascular implantable electronic devices, as compared with the rising implantation rate of these devices.
Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49:1851–9.
Conklin EF, Giannelli Jr S, Nealon Jr TF. Four hundred consecutive patients with permanent transvenous pacemakers. J Thorac Cardiovasc Surg. 1975;69:1–7.
Lai KK, Fontecchio SA. Infections associated with implantable cardioverter defibrillators placed transvenously and via thoracotomies: epidemiology, infection control, and management. Clin Infect Dis. 1998;27:265–9.
Ferguson Jr TB, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. J Thorac Cardiovasc Surg. 1996;111:742–52.
Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol. 2006;29:142–5.
Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009;2:129–34.
Sohail MR, Uslan DZ, Khan AH, et al. Risk factor analysis of permanent pacemaker infection. Clin Infect Dis. 2007;45:166–73.
Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116:1349–55.
Mela T, McGovern BA, Garan H, et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter-defibrillator implants. Am J Cardiol. 2001;88:750–3.
Gil P, Fernández Guerrero ML, Bayona JF, et al. Infections of implantable cardioverterdefibrillators: frequency, predisposing factors and clinical significance. Clin Microbiol Infect. 2006;12:533–7.
Johansen C, Feychting M, Møller M, et al. Risk of severe cardiac arrhythmia in male utility workers: a nationwide danish cohort study. Am J Epidemiol. 2002;156:857–61.
Al-Khatib SM, Lucas FL, Jollis JG, et al. The relation between patients’ outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol. 2005;46:1536–40.
Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001;104:1029–33.
• Viola GM, Awan LL, Darouiche RO. Nonstaphylococcal infections of cardiac implantable electronic devices. Circulation. 2010;121:2085–91. The authors describe the characteristics of 80 individuals with nonstaphylococcal infection of cardiac implantable electronic devices..
•• de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2:29–34. This double-blinded randomized controlled study clearly demonstrated that perioperative antibiotics reduce the rate of infections of cardiac implantable electronic devices..
Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95:2098–107.
Chambers ST. Diagnosis and management of staphylococcal infections of pacemakers and cardiac defibrillators. Intern Med J. 2005;35:S63–71.
• Rohacek M, Weisser M, Kobza R, et al. Bacterial colonization and infection of electrophysiological cardiac devices detected with sonication and swab culture. Circulation. 2010;121:1691–7. This study showed that approximately one-third of individuals with an explanted cardiac implantable electronic device without any sign for infection are asymptomatically bacterially colonized..
Mason PK, Dimarco JP, Ferguson JD, et al.: Sonication of explanted cardiac rhythm management devices for the diagnosis of pocket infections and asymptomatic bacterial colonization. Pacing Clin Electrophysiol. Published ahead of print on June 17, 2010.
Chua JD, Wilkoff BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133:604–8.
Giamarellou H. Nosocomial cardiac infections. J Hosp Infect. 2002;50:91–105.
Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol. 1998;82:480–4.
Catanchin A, Murdock CJ, Athan E. Pacemaker infections: a 10-year experience. Heart Lung Circ. 2007;16:434–9.
Meier-Ewert HK, Gray ME, John RM. Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction. Am Heart J. 2003;146:339–44.
• Grammes JA, Schulze CM, Al-Bataineh M, et al. Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram. J Am Coll Cardiol. 2010;55:886–94. The authors described the feasibility, safety, and clinical outcomes of percutaneous lead extraction in patients who had intracardiac vegetations identified by transesophageal echocardiogram..
Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.
Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–54.
Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354–61.
Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med. 1996;335:407–16.
Wilson WR, Jaumin PM, Danielson GK, et al. Prosthetic valve endocarditis. Ann Intern Med. 1975;82:751–6.
Fariñas MC, Pérez-Vázquez A, Fariñas-Alvarez C, et al. Risk factors of prosthetic valve endocarditis: a case-control study. Ann Thorac Surg. 2006;81:1284–90.
Calderwood SB, Swinski LA, Waternaux CM, et al. Risk factors for the development of prosthetic valve endocarditis. Circulation. 1985;72:31–7.
Hyde JA, Darouiche RO, Costerton JW. Strategies for prophylaxis against prosthetic valve endocarditis: a review article. J Heart Valve Dis. 1998;7:316–26.
Knoll BM, Baddour LM, Wilson WR. Prosthetic valve endocarditis. In: Mandell GL, editor. Principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone; 2004. p. 1113–26.
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.
Lepidi H, Casalta JP, Gouriet F, et al. Infective endocarditis incidentally discovered by pathological examination. J Clin Pathol. 2008;61:233–4.
Hanai M, Hashimoto K, Mashiko K, et al. Active infective endocarditis: management and risk analysis of hospital death from 24 years’ experience. Circ J. 2008;72:2062–8.
McFarland MM. Pathology of infective endocarditis. In: Kaye D, editor. Infective endocarditis. New York: Raven; 1992. p. 57–83.
Zussa C, Galloni MR, Zattera GF, et al. Endocarditis in patients with bioprosthesis: pathology and clinical correlations. Int J Cardiol. 1984;6:719–35.
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394–434.
Habib G, Tribouilloy C, Thuny F, et al. Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases. Heart. 2005;91:954–9.
Tugtekin S, Matschke K, Daubner D, et al. Prosthetic valve endocarditis: importance of surgical treatment. Thorac Cardiovasc Surg. 2007;55:94–8.
López J, Revilla A, Vilacosta I, et al. Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J. 2007;28:760–5.
Baddley JW, Benjamin Jr DK, Patel M, et al. Candida infective endocarditis. Eur J Clin Microbiol Infect Dis. 2008;27:519–29.
Anderson DJ, Olaison L, McDonald JR, et al. Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database. Eur J Clin Microbiol Infect Dis. 2005;24:665–70.
Tang DG, Oyer PE, Mallidi HR. Ventricular assist devices: history, patient selection, and timing of therapy. J Cardiovasc Transl Res. 2009;2:159–67.
Schulman AR, Martens TP, Christos PJ, et al. Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2007;133:841–2.
• Topkara VK, Kondareddy S, Malik F, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90:1270–7. The authors perform a detailed description of 42 patients with infection of the new-generation continuous-flow left ventricular assist devices..
Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis. 2006;6:426–37.
Malani PN, Dyke DB, Pagani FD, Chenoweth CE. Nosocomial infections in left ventricular assist device recipients. Clin Infect Dis. 2002;34:1295–300.
Aslam S, Hernandez M, Thornby J, et al. Risk factors and outcomes of fungal ventricular-assist device infections. Clin Infect Dis. 2010;50:664–71.
Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis. 2005;40:1108–15.
Sivaratnam K, Duggan JM. Left ventricular assist device infections: three case reports and a review of the literature. ASAIO J. 2002;48:2–7.
Poston RS, Husain S, Sorce D, et al. LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant. 2003;22:914–21.
Sinha P, Chen JM, Flannery M, et al. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation. 2000;102 suppl 3:III194–9.
Ankersmit HJ, Edwards NM, Schuster M, et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation. 1999;100(suppl):II211–5.
Ankersmit HJ, Tugulea S, Spanier T, et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet. 1999;354:550–5.
John R. Current axial-flow devices—the HeartMate II and Jarvik 2000 left ventricular assist devices. Semin Thorac. 2008;20:264–72.
Itescu S, John R. Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. Ann Thorac Surg. 2003;75 suppl 6:S58–65.
Gordon SM, Schmitt SK, Jacobs M, et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg. 2001;72:725–30.
Pae WE, Connell JM, Adelowo A, et al. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant. 2007;26:219–29.
Copeland JG, Smith RG, Arabia FA, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859–67.
• Copeland JG, Smith RG, Bose RK, et al. Risk factor analysis for bridge to transplantation with the CardioWest total artificial heart. Ann Thorac Surg. 2008;85:1639–44. The authors reported the risk factor profiles for bridge to transplantation with the CardioWest total artificial heart and summarized reports for other cardiac devices..
Platis A, Larson DF. CardioWest temporary total artificial heart. Perfusion. 2009;24:341–6.
Roussel JC, Sénage T, Baron O, et al. CardioWest (Jarvik) total artificial heart: a single-center experience with 42 patients. Ann Thorac Surg. 2009;87:124–30.
Arabia FA, Copeland JG, Smith RG, et al. International experience with the CardioWest total artificial heart as a bridge to heart transplantation. Eur J Cardiothorac Surg. 1997;11(Suppl):S5–S10.
Frazier OH, Dowling RD, Gray Jr LA, et al. The total artificial heart: where we stand. Cardiology. 2004;101:117–21.
Barbato E, Marco J, Wijins W. Direct stenting. Eur Heart J. 2003;24:394–403.
Kaufmann BA, Kaiser C, Pfisterer ME, Bonetti PO. Coronary stent infection: a rare but severe complication of percutaneous coronary intervention. Swiss Med Wkly. 2005;135:483–7.
Schoenkerman AB, Lundstrom RJ. Coronary stent infections: a case series. Catheter Cardiovasc Interv. 2009;73:74–6.
Cassar A, Holmes Jr DR, Rihal CS, Gersh BJ. Chronic coronary artery disease: diagnosis and management. Mayo Clin Proc. 2009;84:1130–46.
Banai S, Selitser V, Keren A, et al. Prospective study of bacteremia after cardiac catheterization. Am J Cardiol. 2003;92:1004–7.
Hoffman M, Baruch R, Kaplan E, et al. Coronary stent bacterial infection with multiple organ septic emboli. Eur J Intern Med. 2005;16:123–5.
Costa MA, Simon DI. Molecular basis of restenosis and drug-eluting stents. Circulation. 2005;111:2257–73.
Disclosures
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Viola, G.M., Darouiche, R.O. Cardiovascular Implantable Device Infections. Curr Infect Dis Rep 13, 333–342 (2011). https://doi.org/10.1007/s11908-011-0187-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11908-011-0187-7
Keywords
- Cardiac device
- Cardiovascular implantable electronic devices
- CIED
- Bioprosthetic valve
- Defibrillator
- Endocarditis
- Infection
- Mechanical valve
- Pacemaker
- Stent
- Total artificial heart
- TAH
- Valve
- Bioprosthetic valves
- Mechanical valves
- Ventricular assist device
- VAD
- Endocarditis
- Prosthetic valve endocarditis
- PVE
- Transthoracic echocardiogram
- TTE
- Transesophageal echocardiogram
- TEE
- Permanent pacemaker
- PPM
- Coronary artery stents
- Gram-positive bacteria
- Gram-negative bacteria
- Bacteremia
- Staphylococcus
- Streptococcus
- Enterococci
- Percutaneous coronary interventions